Detalles de la búsqueda
1.
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
J Antimicrob Chemother;
77(3): 758-766, 2022 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34849957
2.
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
J Antimicrob Chemother;
75(11): 3373-3378, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812025
3.
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial.
Iran J Pharm Res;
20(4): 278-288, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194446
Resultados
1 -
3
de 3
1
Próxima >
>>